lidaveg
sanofi-aventis australia pty ltd - aflibercept -
simvastatin winthrop
sanofi-aventis australia pty ltd - simvastatin -
zaltrap
sanofi-aventis australia pty ltd - aflibercept -
rilutek tablet 50 mg
sanofi-aventis singapore pte. ltd. - riluzole - tablet, film coated - 50 mg - riluzole 50 mg
zaltrap
sanofi-aventis new zealand limited - aflibercept 25 mg/ml; - concentrate for infusion - 25 mg/ml - active: aflibercept 25 mg/ml excipient: citric acid dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate polysorbate 20 sodium chloride sodium citrate dihydrate sodium hydroxide sucrose water for injection - zaltrap in combination with irinotecan-fluoropyrimidine-based chemotherapy is indicated in adults with metastatic colorectal cancer previously treated with an oxaliplatin-containing regimen.
zaltrap
sanofi-aventis new zealand limited - aflibercept 25 mg/ml; - concentrate for infusion - 25 mg/ml - active: aflibercept 25 mg/ml excipient: citric acid dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate polysorbate 20 sodium chloride sodium citrate dihydrate sodium hydroxide sucrose water for injection - zaltrap in combination with irinotecan-fluoropyrimidine-based chemotherapy is indicated in adults with metastatic colorectal cancer previously treated with an oxaliplatin-containing regimen.
sevelamer hydrochloride sanofi sevelamer hydrochloride 800 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -
sevelamer hydrochloride sanofi sevelamer hydrochloride 400 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -
sevelamer carbonate sanofi sevelamer carbonate 2.4 g powder for oral suspension sachet
sanofi-aventis australia pty ltd - sevelamer carbonate -
sevelamer carbonate sanofi sevelamer carbonate 800 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer carbonate -